Gout is a very common form of inflammatory arthritis, affecting ~9.2 million adults (3.9%) in the U.S. Although the etiology of gout is well understood and effective, inexpensive medications exist to treat gout, gaps in quality of care persist. Below, explore selected content from The Rheumatologist’s collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of gout. New features are added often, so check back frequently.
Highlights: In 2020, the ACR released a new guideline for the management of gout, leaving some rheumatologists unsure what to recommend to their patients. Clearing up the confusion was one aim of the ACR Convergence 2020 session, Evidence-Based Guidance for Optimizing Gout Management. Learn what the experts had to say.
Ethan Craig, MD, MHS, an assistant professor of clinical medicine with the Division of Rheumatology at the University of Pennsylvania, Philadelphia, a rheumatologist at the Corporal Michael J. Crescenz VA Medical Center and the associate physician editor of The Rheumatologist, reviewed the research abstracts related to gout presented at ACR Convergence 2020 and talks about why they stand out.
FEATURED ARTICLE: FAST Results for Febuxostat Safety in Patients with Gout